BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14752879)

  • 41. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
    Heifetz SA; French M; Correa M; Grosfeld JL
    Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
    Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ
    J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric liver transplantation for hepatoblastoma: a single center experience.
    Kim T; Kim DY; Kim KM; Seo JJ; Park KM; Lee YJ; Lee SG
    Transplant Proc; 2012 Mar; 44(2):523-5. PubMed ID: 22410061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Features predicting unresectability in hepatoblastoma.
    D'Antiga L; Vallortigara F; Cillo U; Talenti E; Rugge M; Zancan L; Dall'Igna P; De Salvo GL; Perilongo G
    Cancer; 2007 Sep; 110(5):1050-8. PubMed ID: 17661341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
    Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
    Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
    [No Abstract]   [Full Text] [Related]  

  • 47. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
    Phernambucq EC; Biesma B; Smit EF; Paul MA; vd Tol A; Schramel FM; Bolhuis RJ; Postmus PE
    Br J Cancer; 2006 Aug; 95(4):470-4. PubMed ID: 16909132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
    Seo T; Ando H; Watanabe Y; Harada T; Ito F; Kaneko K; Horibe K; Sugito T; Ito T
    Surgery; 1998 Apr; 123(4):407-14. PubMed ID: 9551066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience.
    De Ioris M; Brugieres L; Zimmermann A; Keeling J; Brock P; Maibach R; Pritchard J; Shafford L; Zsiros J; Czaudzerna P; Perilongo G
    Eur J Cancer; 2008 Mar; 44(4):545-50. PubMed ID: 18166449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
    Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
    J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF; Greenberg ML; Filler RM
    J Pediatr Surg; 1997 Jul; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
    Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
    Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma.
    Bajpai M; Pal K; Agarwala S; Seth T; Gupta AK
    Pediatr Surg Int; 2005 May; 21(5):364-8. PubMed ID: 15838617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
    Häberle B; Maxwell R; Schweinitz DV; Schmid I
    Klin Padiatr; 2019 Nov; 231(6):283-290. PubMed ID: 31645068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor rupture in hepatoblastoma: A high risk factor?
    Pondrom M; Pariente D; Mallon B; Taque S; Branchereau S; Chardot C; Laithier V; Tabone MD; Lejeune J; Faure-Conter C; Saumet L; Vérité C; Aerts I; Brugières L; Fresneau B
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28549. PubMed ID: 32618436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
    Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
    Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
    Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
    Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.